The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

The H5N1 virus is common in wild birds and other animals. While it has not conclusively been found to spread from person to ...

最后,现有mRNA疫苗的中和抗体持久力限制在约6个月,而纳米疫苗则通过抗原的稳定结构,一年仅靠一次加强针就可以对包括变异株在内的新冠病毒维持较高中和抗体效价。 (动物实验标准) ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. Read more at straitstimes.com.

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, ...

With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, scientists and government health ...

HHS Allocates $590 Million to Speed Up the Development of mRNA Vaccines for Pandemic Influenza, Including an H5N1 (Bird Flu) Vaccine ...

There are currently three approved vaccines against the H5N1 avian influenza virus. However, they present challenges for large-scale virus cultivation in case of an outbreak and rapid update of ...

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.